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Abstract
Background: The abundant use of tetracycline antibiotics in veterinary medicine may result in the presence of their
residues in milk at unsafe concentrations that can adversely affect public health. The aim of the current study was to
evaluate the risk of tetracycline residue (TET) intake via milk consumption amongst different age groups of human
consumers in Iran.
Methods: To quantify the drug residues, HPLC analysis was performed under isocratic conditions using UV detection at
355 nm. Milk consumption patterns were determined using a recent nutrition survey in Iran.
Results: The average concentration of total TETs in milk was determined to be 252.41 μg/kg, which is approximately
2.5 times greater than the maximum residue limit (MRL) set by codex. Of the four different tetracycline antibiotics
analyzed, oxytetracyclin had the highest share (86 %) of the determined contamination.
Discussion: Daily exposure to TETs through milk using an average data on milk consumption was estimated to range
from 58–62 μg. but, distribution based exposure to TETs in milk appeared as 0–99.3 μg per day.
Conclusions: Risk characterization of dietary exposure to TETs residue via milk intake in different age groups showed
that considering the standard dietary recommendation that advices on two servings of milk per day (480 ml),
consumers may receive
7–30 % of the determined ADI via bovine milk consumption.
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Background
Tetracyclines (TETs) are a group of broad-spectrum anti-
bacterial agents indicated for use against a large variety of
microorganisms including aerobic, anaerobic, Gram-
positive and Gram-negative pathogenic bacteria, as well as
some types of protozoa. They are widely used in veterinary
medicine for prevention and treatment of infectious
diseases and also serve as growth promoter additives in
animal feed [1]. Although the use of TETs in the treatment
of human infectious disease was more common in the past,
they are still routinely used, especially in patients suscep-
tible to allergic reactions to ß-lactams and macrolides. Four
types of tetracycline antibiotics are routinely used in animal
husbandry practice: oxytetracycline (OXT), tetracycline
(TET), chlortetracycline (CHT) and doxycyclin (DOT). In
cattle, oxytetracycline is frequently applied to treat enter-
itis, endometritis, septicemia, and mastitis, as well as other
bacterial infections [2]. They may be introduced orally
through feed or drinking water, or parenterally via intra-
mammary infusion [3]. In either case, upon administration,
the drug is partially excreted through maternal milk. Its
concentration in milk is approximately 70 % of that of the
concentration within maternal serum [4–6]. Improper
veterinary use of tetracyclines, as well as inadequate
knowledge of the necessary withdrawal time, can easily
make the tetracyclines or their derivatives appear in the
marketed milk.
Intake of contaminated milk can result in adverse
human health effects including allergic reactions, the
development of bacterial resistance, and the risk of
teratogenicity when administrated during the first tri-
mester of pregnancy. Moreover, primary and permanent
teeth discoloration often occurs when milk
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contaminated with tetracycline residues is consumed by
infants or children less than 12 years old [7].
Regulations have been established by food safety author-
ities in order to prevent or reduce the negative health
effects of tetracyclines on consumers; the Food and
Agricultural Organization and World Health Organization
(FAO/WHO) and the European Union (EU) have recom-
mended a maximum residue limit (MRL) of 100 μg/kg for
tetracycline, oxytetracycline and/or chlortetracycline (singly
or in combination) in milk [8–10]. Meanwhile, the U.S.
Food and Drug Administration (FDA) has set an upper
legal level of 300 μg/kg for the combined residues of
TET, OXT and CHT [11]. The Joint Expert Committee
on Food Additives has recommended an acceptable
daily intake (ADI) for TETs residues at a concentration
of 0–30 μg/kg bw/day [8].
In Iran, several studies have been published examining
the presence of antibiotic residues in milk. Chronologically,
the levels of antibiotic residues in milk found to exceed
recommended levels have increased from 5 % in the first
study completed in 2009 to more than 20 % in the latest
one in 2012 [12–15], indicating that in Iran the risk of anti-
biotic intake through milk consumption must be assessed
using both qualitative and quantitative methods. In this
regard, previously published information has been insuffi-
cient in determining the presence of antibiotic residues in
milk as they have primarily focused on the general antibac-
terial activity, while determination of specific antibiotics
was rarely carried out.
The objective of this study was to evaluate the risk
associated with the presence of antibiotic residues in
marketed milk in Iran. A chemical risk assessment is
defined as the likelihood of a chemical having adverse
health effects and is divided into four steps: 1) hazard
identification; 2) hazard characterization/dose-response
assessment; 3) exposure assessment; and 4) risk
characterization [16]. In the first component of the
present study, the utilization pattern of antibiotic drugs
in livestock and poultry farms was surveyed. It was indi-
cated that TETs, in particular oxytetracycline, were in
abundant use on both animal and poultry farms [17].
Secondly, a market study was carried out and the con-
tamination rate of pasteurized and sterilized milk (n =
180) from 25 commercial brands offered in retail was
investigated. Approximately 20 % of the samples tested
were found to have antibiotic residues at levels greater
than the legally permitted levels [18].
In the current study, the analytical determination of
four types of tetracyclines within the previously iden-
tified contaminated milk samples was planned, and
then, based on the existing and representative data on
the average milk consumption for adults and children,




A total of 187 commercial cows' milk samples, consist-
ing of 33 sterilized and 154 pasteurized products, from
24 Iranian dairy brands were randomly collected from
the Shahre-kourd city market from January to July 2012.
Sample size was determined based on the previously re-
ported values of antibiotic contaminated milk samples in
Iran (5–20 %) [12–15]. Also availability of the commercial
brands in the market was considered in sampling. Samples
were sent to the Food and Drink Quality Control labora-
tory of the Shahre-kourd University of Medical Science,
and were examined for the presence of antimicrobials.
Screening test
Screening tests were conducted using a commercial kit
(Eclipse 100-kit (Zeu. Inmunotec, Spain)) by which the
presence of antimicrobial residues could be detected
based on the inhibition of microbial activity. According
to the manufacturing company, the sensitivity of the test
for TETs is between 50–150 μg/kg. Positively detected
milk samples were stored at −20°c until HPLC analysis.
Chemical and reagents
Analytical standards of tetracycline antibiotics, including
tetracycline hydrochloride, oxytetracyclin hydrochloride,
chlortetracyclin hydrochloride and doxycyclin hydrochlor-
ide, were provided from Alderck Company. Analytical
grade chemicals including acetic acid, sodium chloride,
oxalic acid, citric acid, ethylene-diaminetetraacetic acid
(EDTA) and disodium hydrogen phosphate (Na2HPO4)
were provided from Merck, Germany. Methanol and Acet-
onitril of HPLC grade were also from Merck-Germany.
Solid phase extraction cartridges (500 mg, 6 ml) were
provided from Macherey-Nagel Company (Germany).
Preparation of standard curves
Stock solutions of tetracyclines in methanol (Merck-
Germany) at the concentration of 100 μg/ml were
prepared using pharmaceutical standards; working stan-
dards in methanol were made in the concentration rage of
50–400 ng/ml. The working standards were kept in re-
frigerator for less than one month [19].
Preparation milk samples
Two milliliters of 20 % TCA (trichloroacetic acid-Merck-
Germany) and 20 ml of EDTA-McIlvaine buffer were
added to 5 ml of milk sample. EDTA-McIlvaine was pre-
pared using 11.8 g of citric acid monohydrate, 13.72 g of
disodium hydrogen phosphate dehydrate, and 33.62 g of
ethylene-diaminetetraacetic acid disodium salt dissolved
in 1 l of double-distilled water (0.01 M). The mixture was
then mixed thoroughly and centrifuged at 4000 rpm for
20 min. The resultant supernatant was removed and then
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applied to the solid phase extraction (SPE HLB C18) cart-
ridge that had been previously activated with 3 ml metha-
nol followed by rinsing with 2 ml double-distilled water.
After loading each sample, the cartridge was washed with
2 ml methanol solution (5 %) in double-distilled water, the
analytics was eluted with 3 ml of pure methanol, instantly
removed under a nitrogen stream, and the residue was
resolved in 1 ml mobile phase. In each batch of injection,
10 μl of the given aliquot or standard was filtered through
a 0.45-μm micro-filter and injected in to system [20].
Instruments and HPLC condition
The UHPLC-KUNAER system was used (model A69420,
Germany) which was equipped with double pumps (model
A60015, Germany), UV-vis detector (model MW-1
A61031, Germany) set at 355 nm and auto sampler
(model AS-1 A63500, Germany). Separation was carried
out under isocratic conditions using a C18 Column,
250 mm× 4.6 mm I.D., containing 5 μm particles. The
mobile phase consisted of 0.01 M oxalic acid solution,
methanol and acetonitril (60:25:15 v/v/v), and was filtered
through a 0.45-μm micro-filter at an adjusted flow rate of
1 ml/min.
Validity parameters
Obtained validity parameters, including linearity, limit of
detection (LOD), limit of qualification (LOQ), entry-day
precision, and intra-day precision, are listed in Table 1.
Calibration curves of mixed standard TETs were pro-
vided for five concentration levels (50, 100, 200, 300 and
400 ng/ml) in a blank milk sample.
The limit of detection (LOD) and the limit of quantifica-
tion (LOQ) were determined based on signal to noise
ratios. For the entry-day precision, the relative standard
deviation (RSD) of four repeated measurements of a blank
milk sample containing 500 ng/ml mix standard through a
one-day experiment run was considered. For the determin-
ation of intra-day precision, the relative standard deviation
of the repeated measurements of a milk sample containing
100 ng/ml standard mix in blank milk sample through four
subsequent days was taken in to account. A recovery test
was performed using the spiked blank milk in three
concentration levels (100, 200, 300 ng/ml) of mix standard.
The obtained recovery percentages are presented in
Table 2. The highest and lowest recovery rates were
obtained for tetracycline (88.78 %) and chlortetracyclin
(64.68 %) respectively. Based on the European Commis-
sion, Regulation 2002/657/EC, the RSD should be lower
than 15 % [21].
Exposure assessment of TETs residues in milk
Exposure assessment was performed using deterministic
(point estimate) and probabilistic distribution-based or
population-related) approaches for three target groups;
infants, children and adults were included.
Per capita milk consumption was obtained from the
official report released by the deputy head of Iran Dairy
Industries Society (IDIS) [22] as 85–90 kg and used in
the deterministic exposure assessment. The reported re-
sults of three recent Iranian nutrition surveys were used
to derive the lowest, the highest and average milk intake
among adults and children [23–25] in the probabilistic
exposure estimation. The following equations were used
to determine the risk associated with the TETs residue
through milk intake:
Intake of TETs residueðμg=dayÞ ¼ Mean residue concentrationðμg=kgÞ
 daily milk consumption kg=dayð Þ
ð1Þ
%ADI ¼ 100  Intake ðμg=dayÞ




The Statistical Package for Social Science (SPSS) software
Version-19 was used for data analysis using descriptive
statistics.
Results
The screening test revealed that 19.78 % of the samples
were positive for antibacterial residues at levels above
Table 1 Validity parameters in analytical determination of tetracycline residues in milk
Parameter Oxytetracyclin Tetracycline Chlortetracycline Doxycycline
LOD ng/ml 1.18 1.12 1.7 1
LOQ ng/ml 4 4 5 3
Regression coefficient 0.991 0.994 0.966 0.915
Retention Time (min) 4.56 5.01 7.90 11.78
Inter day precision N = 3 day 0.78 1.06 3.09 8.07
Entry day precision 0.59 1.33 3.19 6.13
Linearity equation Y = 0.001376x Y = 0.0157643x Y = 0.0308564x Y = 0.019085x
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the defined MRL. Twenty-eight of the total 178 milk
samples (14.97 %) were detected to have residues below
the regulatory limit and 122 milk samples negatively
responded to the test.
The results of the HPLC determination of TETs res-
idues in the positive samples are presented in Table 3.
Amongst the four investigated types of TETs, oxy-
tetracycline distribution frequency and concentration
levels were most prevalent, as it was found to be
present in all of the tested samples (n = 37) and that it
covered 86.71 % of the total concentration of mea-
sured TET residues. Considering that the standard
limit of TET residues in milk defined by MRL-EU is
100 μg/kg [9, 10], the average concentration of the
four examined drugs among the positive samples
(1090 μg/kg) and in the whole sample population
(252.4 μg/kg) were approximately 11 and 2.5 times
greater than the standard level, respectively. Oxytetra-
cycline in particular had the highest share in this con-
tamination and its mean concentrations in the positive
and total milk samples were 30 and 7.2 times greater
than the mentioned permitted limit, respectively. The
other TET drug types were detected in low frequency;
chlortetracycline and doxycycline residues were found
in just five and two out of the 37 samples. Their mean
values were also measured at concentrations below
the legislated level.
Using a deterministic approach and considering 233–
246 g milk intake per day, the daily intake of TETs residues
through long term milk consumption by every Iranian was
roughly estimated to be 58–62 μg. While, probabilistic ex-
posure estimation using cross sectional studies revealed
that such an intake could be between 8.5–99.3 μg for
adults (more than 18 years old) and 0–28 μg for children
under 12 years old during a short term exposure. For
younger children and infants, since exact data on regular
cows’ milk consumption was not available, frequency dis-
tributed exposure could not be estimated.
In Table 4, the result of risk characterization of TETs
residue via milk consumption is presented. Estimated daily
exposure data for adults and children is also depicted in
this table. The highest level of acceptable daily intake
(ADI) of TETs established by JECFA (30 μg/kg bw /day)
was taken into account for risk characterization.
Based on the presented results, estimated daily exposure
for the high-intake consumers could reach up to about 6 %
of the defined ADI at short term exposure. While, consid-
ering per capita milk consumption in long time, children
are exposed to more possible risk due to their less body
weight.
Table 2 Recovery (%) of tetracyclines spiked in different concentration levels
Spiked samples Oxytetracyclin Tetracycline Chlortetracycline Doxycyclin Total
100 ng/ml 68.67 ± 8.6a 90.73 ± 3.4 69.1 ± 3.1 62.4 ± 10.4 72.73 ± 19.1
Precision 0.41b 0.69 5.29 19.04 1.02
200 ng/ml 63.67 ± 7.9 84.68 ± 2.3 59.76 ± 2.8 65.64 ± 3.1 67.99 ± 6.1
Precision 0.62 0.84 2.21` 2.34 0.16
300 ng/ml 68.14 ± 13.2 72.93 ± 11.2 65.17 ± 3.5 71.47 ± 5.9 69.16 ± 17.4
Precision 0.99 1.63 1.78 2.84 0.46
Mean 66.83 ± 9.9 82.78 ± 5.6 64.68 ± 3.1 66.52 ± 6.4 69.96 ± 14.2
Precision 0.78 1.06 3.09 8.07 0.67
n = 20
aMeans of recovery data ± standard deviation for 20 measurements
bPrecision is expressed as the percentage of relative standard deviation (RSD)
Table 3 Tetracycline residues in commercial milk samples(μg/kg)
Number of positive samples Minimum Maximum Meana Each drug ratio to the total TETs concentration
Oxytetracyclin 37 197.65 2137.27 945.90 86.71
Tetracycline 2 <LOD 241.45 28.71 2.63
Chlortetracycline 5 <LOD 288.19 71.93 6.59
Doxycycline 2 <LOD 206.13 44.283 4.05
Total residues in positive samples 37 220.93 2452.06 1090.83 100
Total residues in total samples 187 252.41b
aThe average concentration in the positive samples
bMean concentration of TET residue in the whole sampled population was calculated as an average of 1090.83 μg/kg for positive samples (20 % of the total
share), 100 μg/kg (maximum residue level) for 15 % of the total share and 25 μg/kg for the rest (65 %) which appeared negative in the screening test
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Discussion
Today, in addition to the adverse effects that can occur
as a result of the use of veterinary drugs, antibiotic
resistance is considered to be a major threat to human
health. The presence of antibiotic residues in foods of
animal origin have attracted attentions as to whether
their long-term intake could be contributing to the
development of antibiotic resistance in humans. The
present study demonstrated that tetracycline residues in
the commercial milk brands marketed in Iran can easily
exceed the safety limits recommended by the EU. The
average concentration of oxytetracycline, tetracycline,
chlortetracycline and, doxycycline residues in the milk
samples studied (n = 187) were found to be 218.86, 6.63,
16.66, and 10.22 μg/kg, respectively. However, all of the
tested samples in the present study were compliant with
the standards set by the FDA as the sum of concentra-
tion of tetracycline, oxytetracycline, chlortetracycline
and doxycycline were less than the MRL set by FDA
(300 μg/kg). This difference may be in part due to the
different dairy consumption patterns in the US and
European zones versus those in Iran, and could be indi-
cative of the necessity to establish national standards
based on the dietary intake patterns in Iran.
Recently, several descriptive studies in Iran have been
carried out on the presence of tetracycline residues in
milk. However, the reported contamination levels were
less than those found in the current study. In one of the
previous studies which examined 90 pasteurized milk
samples, the researchers showed that 7.8 % of the tested
samples were contaminated with oxytetracycline and
tetracycline residues at concentrations far below the safe
limit [26]. Another study investigated the residue levels of
three drugs of the tetracycline family including tetracyc-
line, oxytetracycline and chlortetracycline (TCs) in differ-
ent types of thermally-processed bovine milk collected
from Ardebil. The violation rate of 24.4 %, 30 % and
28.6 % for pasteurized, sterilized and raw milk samples
were reported respectively, while the overall concentration
of tested TETs in milk samples averaged as 97.6 μg/kg
[27]. In a similar study conducted in the U.S, on average,
62.2 μg/kg of TETs were identified in the marketed milk
samples, in which 57.2 % of the total detected contamin-
ation was due to oxytetracycline [5]. In another study
carried out in Ethiopia, each kilogram of raw marketed
milk was revealed to contain 142 μg of oxytetracycline
residue [28]. In Yugoslavia, Vragović et al. reported that,
on average, the examined milk samples were contami-
nated with 1.5 μg/kg of tetracycline [29]. This was sig-
nificantly lower than the levels identified in the present
study (6.63 μg/kg). This suggests that tetracycline-
derivative residues in milk in Iran are more controver-
sial than in the aforementioned countries. However, in a
report from Romania, TET contamination of milk aver-
aged 272.5 μg/kg, which is comparable to the results of
the current study [30]. Beta-lactam drugs such as peni-
cillin were previously found as a commonly consumed
veterinary antibiotic through food in US [31].
In the present study, with respect to the exposure esti-
mation, for children group, the deterministic approach
resulted in a higher estimated daily exposure to TETs
than the probabilistic model. This could be due to the
low level of milk intake in a group of children studied in
the used nutritional survey. Although none of the inves-
tigated groups in the present study received the TETs
residues at a level greater than the higher board of the
ADI (30 μg/kg bw/day), considering the standard dietary
recommendation that advise on 2 servings of milk per
day (480 ml), consumers may get 7–30 % of the deter-
mined ADI via bovine milk consumption. The estimated
risks for children passing their infancy could be several
times more than the average of the whole society, when
bovine milk is being introduced to them and being re-
placed by breast-milk.
Since TET residues may also be found in additional food
sources, such as eggs and meat, it is possible that a societal
group may receive residues of this drug type at a level
greater than the defined ADI if several food sources are
contaminated with tetracycline residues. A risk assessment
study on TET residues through milk consumption carried
Table 4 Risk characterization of dietary exposure to tetracycline residuesa via milk intake in different age groups
Age group Body weight
(Kg)b
Probabilistic Deterministic
Low consumersc Average Consumersd High Consumerse Per capita consumptionf
EDIg (μg/Kgbw/d %ADI EDI (μg/Kgbw/d %ADI EDI (μg/Kgbw/d %ADI EDI (μg/Kgbw/d %ADI
Adults (>18y) 60 0.141 0.47 0.7 2.3 1.65 5.5 0.96 3.2
Children (6 < y < 12) 30 - - 0.44 1.46 0.92 3.16 4.13 13.7
Children (2 < y < 3) 13 ND ND ND ND ND ND 4.43 14.7
aThe average concentration of tetracycline in the total milk samples (252.4 μg/kg) was taken in to consideration in all cases
bBody weights for different age groups were derived from FAO/WHO guideline and relevant nutritional studies
cThe lowest amount of milk intake among Iranian adults and children were adapted from [24] as 33.6 ml/day and [25] as negligible, respectively
dThe average amount of milk intake among Iranian adults and children were adapted from [23] as 165 ml/day and [25] as 52 ml/day, respectively
eThe highest amount of milk intake among Iranian adults and children were obtained from [24] as 393 ml/day and [25] as 113 ml/day, respectively
fPer capita milk consumption data is considered as 246 g/d (the upper side of the rage announced by IDIS)
gEstimated daily intake (EDI):[Milk consumption X 252.41(mean concentration of TETs in milk)/1000]/body weight
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out by the Environmental Protection Agency revealed that
the estimated daily intake of oxytetracycline residues for
Americans was 9.6 μg/person/day, which accounted for a
low risk [32]. In Yugoslavia, a similar study showed that
the hazards associated with tetracycline residue intake via
milk was negligible [29].
It should be mentioned that in Iran, the average con-
sumption of milk is lower than the recommended daily
allowance (RDA) of two servings (or 500 ml) per day
[23]. Therefore, increases in milk and dairy product in-
take at the advice of nutritionists can increase the risk of
TET uptake through the food chain. Until recently, no
national or administrative program has been introduced
to monitor the presence of drug residues in milk in Iran.
The results of the present study can be informative for
the safety authorities to instigate new policies to restrict
the present potential risk.
Conclusion
In the present study, the average concentration of total
TETs in milk was determined as 2.5 times greater than
the maximum residue limit (MRL) set by codex and oxy-
tetracyclin had the highest share in this contamination.
Daily exposure to Tetracycline residues intake through
milk considering long term and short term milk con-
sumption were estimated to range from 58–62 μg and
0–99.3 μg per person.
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